Investigation of insulin resistance during diabetic ketoacidosis: Role of counterregulatory substances and effect of insulin therapy (Q41299057)

29 September 2017

Investigation of insulin resistance during diabetic ketoacidosis: role of counterregulatory substances and effect of insulin therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A408581

29 June 2022

Investigation of insulin resistance during diabetic ketoacidosis: Role of counterregulatory substances and effect of insulin therapy (English)

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

23 April 2023

main subject

ketoacidosis

0 references

diabetic ketoacidosis

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

23 April 2023

author name string

H. N. Ginsberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A408581

29 June 2022

language of work or name

1 reference

1 October 1977

1 reference

full work available at URL

29 September 2017

https://api.elsevier.com/content/article/PII:0026049577900415?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

https://api.elsevier.com/content/article/PII:0026049577900415?httpAccept=text/plain

23 April 2023

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

23 April 2023

1 reference

29 September 2017

26

1 reference

29 September 2017

1135-1146

1 reference

29 September 2017

10

1 reference

INHIBITION OF INSULIN BY ACIDOSIS

29 September 2017

3

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Improvement in both insulin sensitivity and release following diabetic coma

23 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Humoral insulin antagonism associated with diabetic acidosis

23 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance

23 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Diurnal serum growth hormone levels in poorly and well-controlled juvenile diabetics

23 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Cortisol Secretion in Acidotic and Nonacidotic Diabetes Mellitus

23 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration.

23 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Treatment of diabetic coma with continuous low-dose infusion of insulin

23 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

23 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Acetoacetate as fuel of respiration in the perfused rat heart

23 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Treatment of Severe Diabetes Mellitus by Insulin Infusion

23 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Continuous intravenous infusion of small doses of insulin in treatment of diabetic ketoacidosis

23 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis

23 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes

23 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Use of Polyethylene Glycol to Separate Free and Antibody-Bound Peptide Hormones in Radioimmunoassays†

23 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma

23 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

A new colorimetric micro-determination of free fatty acids in serum

23 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man

23 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon

23 April 2023

25

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Role of glucagon and other hormones in development of diabetic ketoacidosis

23 April 2023

26

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia

23 April 2023

27

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

23 April 2023

Gluconeogenesis

28

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Glucocorticoid Inhibition of Glucose Uptake by Peripheral Tissues: Old and New Evidence, Molecular Mechanisms, and Physiological Significance

23 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

CRITICAL FACTORS IN EXCESSIVE SERUM-INSULIN RESPONSE TO GLUCOSE. OBESITY IN MATURITY-ONSET DIABETES AND GROWTH HORMONE IN ACROMEGALY

23 April 2023

30

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Glucagon and the Insulin:Glucagon Ratio in Diabetes and Other Catabolic Illnesses

23 April 2023

31

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin

23 April 2023

32

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

Failure of somatostatin to correct manifest diabetic ketoacidosis

23 April 2023

33

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90041-5

23 April 2023

Identifiers

1 reference

29 September 2017

1 reference